The Latest Research on Baricitinib, Eli Lilly’s Arthritis Drug Used to Treat COVID-19
Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, [...]
| Categories: covid-19, pocn-rheumatology
Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, has been the subject of several clinical trials in the fight to treat COVID-19. A […]
Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, [...]
A small study published in the Annals of Internal Medicine [...]